We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+10.51%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.21B
AUM Growth
+$355M
Cap. Flow
+$316M
Cap. Flow %
26.21%
Top 10 Hldgs %
40.06%
Holding
747
New
182
Increased
169
Reduced
181
Closed
163

Sector Composition

Rank Sector Weight
1 Healthcare 36.03%
2 Financials 28.77%
3 Technology 9.99%
4 Energy 5.75%
5 Consumer Discretionary 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRLSW icon
351
Borealis Foods Inc Warrant
BRLSW
$853K
$15.2K ﹤0.01%
265,193
RMGCW
352
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
$15.1K ﹤0.01%
136,773
+36,773
+37% +$4K
EVGRW
353
DELISTED
Evergreen Corporation Warrant
EVGRW
$15K ﹤0.01%
495,560
-150,035
-23% -$11.1K
FORLW
354
DELISTED
Four Leaf Acquisition Corp Warrants
FORLW
$14.8K ﹤0.01%
+120,994
New +$12.8K
KNSW.WS
355
DELISTED
KnightSwan Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
KNSW.WS
$14.8K ﹤0.01%
424,005
-21,320
-5% -$1.55K
ALLG.WS
356
DELISTED
Allego N.V. Warrants
ALLG.WS
$14.5K ﹤0.01%
50,000
-116,647
-70% -$23.6K
GDSTR
357
DELISTED
Goldenstone Acquisition Limited Rights
GDSTR
$14.3K ﹤0.01%
95,545
-372,423
-80% -$63.8K
OPA.WS
358
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
$14.3K ﹤0.01%
373,017
+2,531
+0.7% +$133
INTEW
359
DELISTED
Integral Acquisition Corporation 1 Warrants
INTEW
$14.1K ﹤0.01%
175,849
-106,908
-38% -$5.64K
PGY icon
360
Pagaya Technologies
PGY
$1.8B
$14K ﹤0.01%
+833
New +$10.4K
GRMLW
361
Greenland Mines Ltd Warrant
GRMLW
$13.7K ﹤0.01%
263,612
+2,516
+1% +$173
SNDL icon
362
Sundial Growers
SNDL
$303M
$13.7K ﹤0.01%
10,000
ONMDW icon
363
OneMedNet Corp Warrant
ONMDW
$1.05M
$13.6K ﹤0.01%
544,840
-37,796
-6% -$1.06K
CLDI.WS
364
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$13.5K ﹤0.01%
103,678
-27,900
-21% -$2.26K
IMAQR
365
DELISTED
International Media Acquisition Corp. Rights
IMAQR
$13.4K ﹤0.01%
272,800
BFAC.WS
366
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
$13.4K ﹤0.01%
150,000
-180,587
-55% -$15.9K
ZEOWW
367
Zeo Energy Corp Warrants
ZEOWW
$13.3K ﹤0.01%
181,068
+156,268
+630% +$10.7K
NBSTW
368
DELISTED
Newbury Street Acquisition Corporation Warrants
NBSTW
$13.2K ﹤0.01%
69,493
-100
-0.1% -$17
RACYW
369
DELISTED
Relativity Acquisition Corp. Warrant
RACYW
$13.2K ﹤0.01%
279,989
LTCHW
370
DELISTED
Latch, Inc. Warrant expiring 6/4/2026
LTCHW
$13K ﹤0.01%
122,795
-2,950
-2% -$251
CETUW
371
DELISTED
Cetus Capital Acquisition Corp. Warrant
CETUW
$13K ﹤0.01%
129,690
-10,410
-7% -$727
ZFOXW
372
DELISTED
ZeroFox Holdings, Inc. Warrants
ZFOXW
$12.8K ﹤0.01%
+438,314
New +$21.4K
QOMOR
373
DELISTED
Qomolangma Acquisition Corp. Right
QOMOR
$12.8K ﹤0.01%
91,100
VSACW
374
DELISTED
Vision Sensing Acquisition Corp. Warrants
VSACW
$12.6K ﹤0.01%
318,453
-46,118
-13% -$2.08K
MITAW
375
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$12.5K ﹤0.01%
+83,633
New +$8.71K

Similar funds

Cowen and Company's Q2 2023 Portfolio in Review

As of Q2 2023, Cowen and Company held 747 positions worth $1.21B, up 42% from $851M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cowen and Company deployed $316M of net new capital in Q2 2023, opening 182 new positions and adding to 169 existing holdings. Its largest new stake was NVIDIA: 1,927,500 shares worth $81.5M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 38% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Avadel Pharmaceuticals, an estimated $13.9M trimmed.

  • Cowen and Company's largest Q2 2023 buy was NVIDIA: 1,927,500 shares worth $81.5M.
  • Cowen and Company added most to Ares Acquisition Corporation in Q2 2023, an estimated $15.9M increase.
  • Cowen and Company's biggest Q2 2023 reduction was Avadel Pharmaceuticals, cutting an estimated $13.9M.
  • Cowen and Company fully exited Sylvamo in Q2 2023, selling an estimated $99.5M.
  • Cowen and Company's ten largest holdings make up 40% of its $1.21B portfolio in Q2 2023.
  • Cowen and Company opened 182 new positions and closed 163 in Q2 2023.
  • Cowen and Company's portfolio value rose 42% quarter-over-quarter to $1.21B.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.